Cargando…

Is radioactive iodine- ( 131 ) treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?

OBJECTIVE: Much controversy relates to the risk of non-synchronous second primary malignancies (NSSPM) after radioactive iodine treatment (RAI-131) in differentiated thyroid cancer (DTC) patients. This study evaluated the relationship between RAI-131 and NSSPM in DTC survivors with long-term follow-...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Marcelo Cruzick, Momesso, Denise P., Vaisman, Fernanda, Vieira, Leonardo, Martins, Rosangela Aparecida Gomes, Corbo, Rossana, Vaisman, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118921/ https://www.ncbi.nlm.nih.gov/pubmed/26222230 http://dx.doi.org/10.1590/2359-3997000000078

Ejemplares similares

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy
por: Súss, Shirlei Kugler Aiçar, et al.
Publicado: (2018)

Thyroid Carcinoma in Children and Adolescents—Systematic Review of the Literature
por: Vaisman, Fernanda, et al.
Publicado: (2011)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
por: Barbosa, Mayara Peres, et al.
Publicado: (2017)

Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm
por: Vaisman, Fernanda, et al.
Publicado: (2013)

Low dosage of 131iodine effects on chromosomes.
por: Rodrigues, Claudia Lopes, et al.
Publicado: (2003)

Therapeutic applications of radioactive (131)iodine: Procedures and incidents with capsules
por: Al Aamri, Marwa, et al.
Publicado: (2016)

Outcomes of Radioactive Iodine ((131)I) Therapy among Hyperthyroid patients
por: Khan, Muhammad Sajjad Ali, et al.
Publicado: (2023)

Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
por: Mortazavi, Seyed Mohammad Javad, et al.
Publicado: (2023)

Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level
por: Yartsev, Vasily D, et al.
Publicado: (2023)

Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine
por: Sundaram, P. Shanmuga, et al.
Publicado: (2011)

Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020)

Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014)

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016)

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose
por: Wong, Ka Kit, et al.
Publicado: (2018)

DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019)

Incidence of Hypothyreoidism after Radioactive Iodine–I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose
por: Beslic, Nermina, et al.
Publicado: (2017)

Efficacy of a Graphene Oxide/Chitosan Sponge for Removal of Radioactive Iodine-131 from Aqueous Solutions
por: Suksompong, Tanate, et al.
Publicado: (2021)

Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?
por: da Silva Breder, Julia Ramalho Amalio, et al.
Publicado: (2022)

Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010)

Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases
por: Al-Qahtani, Khalid Hussain, et al.
Publicado: (2014)

Preparation and Characterization of Hyaluronic Acid-Polycaprolactone Copolymer Micelles for the Drug Delivery of Radioactive Iodine-131 Labeled Lipiodol
por: Chen, Shih-Cheng, et al.
Publicado: (2017)

(131)I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine
por: Brudecki, K., et al.
Publicado: (2020)

Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
por: Iizuka, Yusuke, et al.
Publicado: (2023)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer
por: Andrade, Fernanda, et al.
Publicado: (2019)

Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer
por: Vaisman, Fernanda, et al.
Publicado: (2011)

Serum positive thyroglobulin antibodies: an old problem with new questions
por: Vaisman, Fernanda
Publicado: (2017)

Radioactive (131)Iodine Body Burden and Blood Dose Estimates in Treatment for Differentiated Thyroid Cancer by External Probe Counting
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2016)

A False Positive I-131 Metastatic Survey Caused by Radioactive Iodine Uptake by a Benign Thymic Cyst
por: Singh, Avneet K., et al.
Publicado: (2017)

Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer
por: Iwano, Shingo, et al.
Publicado: (2020)

Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer
por: Nobre, Gabriela Maia, et al.
Publicado: (2021)

Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131
por: PICIU, DOINA, et al.
Publicado: (2016)

Quantification of radioactivity by planar gamma-camera images, a promoted method of absorbed dose in the thyroid after iodine-131 treatment
por: Li, Yuhao, et al.
Publicado: (2018)

Radioactive iodine (I-131) therapy isolation rooms: Introduction of lead glass window on the wall for patient comfort and better ambience
por: Al Aamri, Marwa, et al.
Publicado: (2019)

Radioactive Iodine-131 as a Definitive Treatment in Rare Association of Down Syndrome With Hyperthyroidism: A Case Report and Review of Literature
por: Khan, Shoukat H., et al.
Publicado: (2017)

Treating Hyperthyroidism with Radioactive Iodine
por: Harding, L K
Publicado: (1993)

Radioactive iodine and female fertility
por: Navarro, Pino, et al.
Publicado: (2022)

Use of Iodine-131 to Tellurium-132 Ratios for Assessing the Relationships between Human Inhaled Radioactivity and Environmental Monitoring after the Accident in Fukushima
por: Uchiyama, Koji, et al.
Publicado: (2018)

Iodine-131: Lack of efficacy: case report
Publicado: (2022)

Iodine Uptake in Retroperitoneal Cysts after Radioactive Iodine Treatment
por: Lee, Ji Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ueecb6fvu45an1klj2q45ehu9n